|
Delayed
Nasdaq Stockholm
10:50:08 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 0.1845 SEK | -3.40% |
|
-0.54% | -35.04% |
| 06-01 | Flerie portfolio company Xintela reports positive study results for stem cell product | FW |
| 06-01 | Xintela Presents Positive Results from Clinical Study with Its Stem Cell Product XSTEM | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq Stockholm
XINT 0.1845 kr
-3.40%
91.17K
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq Stockholm
| XINT | 0.1845SEK | -3.40% | 91.17K kr | |
Deutsche Boerse AG
| 1XT | 0.005200EUR | -3.70% | 0 € |
- Stock Market
- Stocks
- XINT Stock
- Charts Xintela AB
Select your edition
All financial news and data tailored to specific country editions
